Home Markets US FDA puts Kezar Life Sciences’ lupus treatment trial on hold after patient deaths US FDA puts Kezar Life Sciences’ lupus treatment trial on hold after patient deaths Andrew M Oct 05, 2024 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/us-fda-puts-clinical-hold-on-kezar-life-sciences-lupus-treatment-trial-3649995 FDA Kezar Life Sciences lupus Market Updates www.investing.com/news/stock-market-news/us-fda-puts-clinical-hold-on-kezar-life-sciences-lupus-treatment-trial-3649995